Human and Rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H Demonstrate a Conserved Capacity To Restrict Vif-Deficient HIV-1
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Successful intracellular pathogens must evade or neutralize the innate immune defenses of their host cells and render the cellular environment permissive for replication. For example, to replicate efficiently in CD4 + T lymphocytes, human immunodeficiency virus type 1 (HIV-1) encodes a protein called viral infectivity factor (Vif) that promotes pathogenesis by triggering the degradation of the retrovirus restriction factor APOBEC3G. Other APOBEC3 proteins have been implicated in HIV-1 restriction, but the relevant repertoire remains ambiguous. Here we present the first comprehensive analysis of the complete, seven-member human and rhesus APOBEC3 families in HIV-1 restriction. In addition to APOBEC3G, we find that three other human APOBEC3 proteins, APOBEC3D, APOBEC3F, and APOBEC3H, are all potent HIV-1 restriction factors. These four proteins are expressed in CD4 + T lymphocytes, are packaged into and restrict Vif-deficient HIV-1 when stably expressed in T cells, mutate proviral DNA, and are counteracted by HIV-1 Vif. Furthermore, APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H of the rhesus macaque also are packaged into and restrict Vif-deficient HIV-1 when stably expressed in T cells, and they are all neutralized by the simian immunodeficiency virus Vif protein. On the other hand, neither human nor rhesus APOBEC3A, APOBEC3B, nor APOBEC3C had a significant impact on HIV-1 replication. These data strongly implicate a combination of four APOBEC3 proteins—APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H—in HIV-1 restriction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evolutionary and biomedical insights from the rhesus macaque genome.
Gibbs, R. A., Rogers, J., Katze, M. G., Bumgarner, R., Weinstock, G. M., Mardis, E. R., Remington, K. A., Strausberg, R. L., Venter, J. C., Wilson, R. K., et al. (2007) · Science · doi:10.1126/science.1139247 · Cited by 1,403 · cited 2×
“To begin these analyses, we first aligned the publicly available rhesus macaque genomic sequence with trace files from the NCBI WSG project for rhesus macaque, as well as with available rhesus high-throughput genomic sequences (HTGS) and expressed sequence tags (EST), to generate a locus assembly (11).”
BackgroundMethodSelf-citationDNA Deamination Mediates Innate Immunity to Retroviral Infection
Harris, R. S., Bishop, K. N., Sheehy, A. M., Craig, H. M., Petersen-Mahrt, S. K., Watt, I. N., Neuberger, M. S., & Malim, M. H. (2003) · Cell · doi:10.1016/s0092-8674(03)00423-9 · Cited by 1,266
Self-citationSpecies-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif
Mariani, R., Chen, D., Schröfelbauer, B., Navarro, F., König, R., Bollman, B., Münk, C., Nymark-McMahon, H., & Landau, N. R. (2003) · Cell · doi:10.1016/s0092-8674(03)00515-4 · Cited by 903
Small-Molecule Inhibition of TNF-α
He, M. M., Smith, A. S., Oslob, J. D., Flanagan, W. M., Braisted, A. C., Whitty, A., Cancilla, M. T., Wang, J., Lugovskoy, A. A., Yoburn, J. C., et al. (2005) · Science · doi:10.1126/science.1116304 · Cited by 620
Cytidine Deamination of Retroviral DNA by Diverse APOBEC Proteins
Bishop, K. N., Holmes, R. K., Sheehy, A. M., Davidson, N. O., Cho, S.-J., & Malim, M. H. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.057 · Cited by 619
HIV-1 Accessory Proteins—Ensuring Viral Survival in a Hostile Environment
Malim, M. H., & Emerman, M. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.04.008 · Cited by 551
Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G
Sawyer, S. L., Emerman, M., & Malik, H. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020275 · Cited by 485 · cited 2×
“These proteins undergo high rates of amino acid substitution, or positive selection, which, together with locus expansion, are consistent with numerous historical and ongoing host-pathogen conflicts (41).”
BackgroundA second human antiretroviral factor, APOBEC3F, is suppressed by the HIV‐1 and HIV‐2 Vif proteins
Wiegand, H. L., Doehle, B. P., Bogerd, H. P., & Cullen, B. R. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600246 · Cited by 470
APOBEC3F Properties and Hypermutation Preferences Indicate Activity against HIV-1 In Vivo
Liddament, M. T., Brown, W. L., Schumacher, A. J., & Harris, R. S. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.050 · Cited by 440
Self-citationRefsland, E. W., Stenglein, M. D., Shindo, K., Albin, J. S., Brown, W. L., & Harris, R. S. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq174 · Cited by 363
Self-citationAPOBEC3 Proteins Inhibit Human LINE-1 Retrotransposition
Muckenfuss, H., Hamdorf, M., Held, U., Perković, M., Löwer, J., Cichutek, K., Flory, E., Schumann, G. G., & Münk, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601716200 · Cited by 356
APOBEC3 proteins mediate the clearance of foreign DNA from human cells
Stenglein, M. D., Burns, M. B., Li, M., Lengyel, J., & Harris, R. S. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1744 · Cited by 328
Self-citationHolmes, R. K., Koning, F. A., Bishop, K. N., & Malim, M. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607298200 · Cited by 308
APOBEC3B and APOBEC3C Are Potent Inhibitors of Simian Immunodeficiency Virus Replication
Yu, Q., Chen, D., König, R., Mariani, R., Unutmaz, D., & Landau, N. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408802200 · Cited by 293
APOBEC3B and APOBEC3F Inhibit L1 Retrotransposition by a DNA Deamination-independent Mechanism
Stenglein, M. D., & Harris, R. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602367200 · Cited by 277
Self-citationHIV vaccine design: insights from live attenuated SIV vaccines
Koff, W. C., Johnson, P. R., Watkins, D. I., Burton, D. R., Lifson, J. D., Hasenkrug, K. J., McDermott, A. B., Schultz, A., Zamb, T. J., Boyle, R., et al. (2006) · Nature Immunology · doi:10.1038/ni1296 · Cited by 256
Identification of APOBEC3DE as Another Antiretroviral Factor from the Human APOBEC Family
Dang, Y., Wang, X., Esselman, W. J., & Zheng, Y.-H. (2006) · Journal of Virology · doi:10.1128/jvi.01123-06 · Cited by 255
A new reporter cell line to monitor HIV infection and drug susceptibility in vitro
Gervaix, A., West, D., Leoni, L. M., Richman, D. D., Wong-Staal, F., & Corbeil, J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4653 · Cited by 252
Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif
Doehle, B. P., Schäfer, A., & Cullen, B. R. (2005) · Virology · doi:10.1016/j.virol.2005.06.005 · Cited by 229
Identification of Highly Attenuated Mutants of Simian Immunodeficiency Virus
Desrosiers, R. C., Lifson, J. D., Gibbs, J. S., Czajak, S. C., Howe, A. Y. M., Arthur, L. O., & Johnson, R. P. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1431-1437.1998 · Cited by 224
Antiretroelement Activity of APOBEC3H Was Lost Twice in Recent Human Evolution
OhAinle, M., Kerns, J. A., Li, M. M. H., Malik, H. S., & Emerman, M. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.07.005 · Cited by 204
Small-molecule inhibition of HIV-1 Vif
Nathans, R., Cao, H., Sharova, N., Ali, A., Sharkey, M., Stranska, R., Stevenson, M., & Rana, T. M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1496 · Cited by 198
LaRue, R. S., Jónsson, S. R., Silverstein, K. A., Lajoie, M., Bertrand, D., El-Mabrouk, N., Hötzel, I., Andrésdóttir, V., Smith, T. P., & Harris, R. S. (2008) · BMC Molecular Biology · doi:10.1186/1471-2199-9-104 · Cited by 191
Self-citationInteractions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics
Albin, J. S., & Harris, R. S. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001343 · Cited by 186
Self-citationAdaptive Evolution and Antiviral Activity of the Conserved Mammalian Cytidine Deaminase APOBEC3H
OhAinle, M., Kerns, J. A., Malik, H. S., & Emerman, M. (2006) · Journal of Virology · doi:10.1128/jvi.80.8.3853-3862.2006 · Cited by 182
Langlois, M.-A. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki343 · Cited by 181
Host Restriction Factors Blocking Retroviral Replication
Wolf, D., & Goff, S. P. (2008) · Annual Review of Genetics · doi:10.1146/annurev.genet.42.110807.091704 · Cited by 179
Janini, M., Rogers, M., Birx, D. R., & McCutchan, F. E. (2001) · Journal of Virology · doi:10.1128/jvi.75.17.7973-7986.2001 · Cited by 175
Kieffer, T. L., Kwon, P., Nettles, R. E., Han, Y., Ray, S. C., & Siliciano, R. F. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1975-1980.2005 · Cited by 172
Polymorphisms and Splice Variants Influence the Antiretroviral Activity of Human APOBEC3H
Harari, A., Ooms, M., Mulder, L. C. F., & Simon, V. R. (2008) · Journal of Virology · doi:10.1128/jvi.01665-08 · Cited by 164
Miyagi, E., Opi, S., Takeuchi, H., Khan, M. H., Goila-Gaur, R., Kao, S., & Strebel, K. (2007) · Journal of Virology · doi:10.1128/jvi.01361-07 · Cited by 150
Schumacher, A. J., Haché, G., MacDuff, D. A., Brown, W. L., & Harris, R. S. (2008) · Journal of Virology · doi:10.1128/jvi.02391-07 · Cited by 148
Self-citationSakai, K., Dimas, J., & Lenardo, M. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509417103 · Cited by 145
Human cellular restriction factors that target HIV-1 replication
Strebel, K., Luban, J., & Jeang, K.-T. (2009) · BMC Medicine · doi:10.1186/1741-7015-7-48 · Cited by 141
Two-stepping through time: mammals and viruses
Meyerson, N. R., & Sawyer, S. L. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.03.006 · Cited by 133 · cited 1×
“Finally, they may be functionally conserved in closely related species such as the rhesus macaque, though this may not be true in all cases, since ongoing evolutionary struggles between host and pathogen may lead to rapid diversification (29).”
BackgroundSuspène, R., Henry, M., Guillot, S., Wain–Hobson, S., & Vartanian, J. (2004) · Journal of General Virology · doi:10.1099/vir.0.80426-0 · Cited by 126
Analysis of Human APOBEC3H Haplotypes and Anti-Human Immunodeficiency Virus Type 1 Activity
Wang, X., Abudu, A., Son, S., Dang, Y., Venta, P. J., & Zheng, Y.-H. (2011) · Journal of Virology · doi:10.1128/jvi.02049-10 · Cited by 114
Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates
Zennou, V., & Bieniasz, P. D. (2006) · Virology · doi:10.1016/j.virol.2005.12.035 · Cited by 107
LaRue, R. S., Lengyel, J., Jönsson, S., Andrésdóttir, V., & Harris, R. S. (2010) · Journal of Virology · doi:10.1128/jvi.00685-10 · Cited by 104
Self-citationRestriction of HIV-1 by APOBEC3G is cytidine deaminase-dependent
Browne, E. P., Allers, C., & Landau, N. R. (2009) · Virology · doi:10.1016/j.virol.2009.02.026 · Cited by 97
Land, A. M., Ball, T. B., Luo, M., Pilon, R., Sandstrom, P. A., Embree, J. E., Wachihi, C., Kimani, J., & Plummer, F. A. (2008) · Journal of Virology · doi:10.1128/jvi.01115-08 · Cited by 91
Henriet, S., Sinck, L., Bec, G., Gorelick, R. J., Marquet, R., & Paillart, J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm542 · Cited by 90
Stenglein, M. D., Matsuo, H., & Harris, R. S. (2008) · Journal of Virology · doi:10.1128/jvi.02471-07 · Cited by 80
Self-citationA Single Amino Acid Difference in Human APOBEC3H Variants Determines HIV-1 Vif Sensitivity
Zhen, A., Wang, T., Zhao, K., Xiong, Y., & Yu, X.-F. (2009) · Journal of Virology · doi:10.1128/jvi.01509-09 · Cited by 74
Piantadosi, A. L., Humes, D. G., Chohan, B. H., McClelland, R. S., & Overbaugh, J. M. (2009) · Journal of Virology · doi:10.1128/jvi.00280-09 · Cited by 73
Haché, G., Shindo, K., Albin, J. S., & Harris, R. S. (2008) · Current Biology · doi:10.1016/j.cub.2008.04.073 · Cited by 73
Self-citationSmith, J. L., & Pathak, V. K. (2010) · Journal of Virology · doi:10.1128/jvi.01437-10 · Cited by 71
The Range of Human APOBEC3H Sensitivity to Lentiviral Vif Proteins
Li, M. M. H., Wu, L. I., & Emerman, M. (2009) · Journal of Virology · doi:10.1128/jvi.01344-09 · Cited by 70
Vpr.A3A Chimera Inhibits HIV Replication
Aguiar, R. S., Lovšin, N., Tanuri, A., & Peterlin, B. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706436200 · Cited by 64
Antiretroviral Activity and Vif Sensitivity of Rhesus Macaque APOBEC3 Proteins
Virgen, C. A., & Hatziioannou, T. (2007) · Journal of Virology · doi:10.1128/jvi.01760-07 · Cited by 58
A Single Amino Acid in Human APOBEC3F Alters Susceptibility to HIV-1 Vif
Albin, J. S., LaRue, R. S., Weaver, J. A., Brown, W. L., Shindo, K., Harjes, E., Matsuo, H., & Harris, R. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.173161 · Cited by 57
Self-citationThe Localization of APOBEC3H Variants in HIV-1 Virions Determines Their Antiviral Activity
Ooms, M., Majdak, S., Seibert, C. W., Harari, A., & Simon, V. R. (2010) · Journal of Virology · doi:10.1128/jvi.00754-10 · Cited by 54
Albin, J. S., Haché, G., Hultquist, J. F., Brown, W. L., & Harris, R. S. (2010) · Journal of Virology · doi:10.1128/jvi.00632-10 · Cited by 54
Self-citationStably Expressed APOBEC3F Has Negligible Antiviral Activity
Miyagi, E., Brown, C. R., Opi, S., Khan, M. H., Goila-Gaur, R., Kao, S., Walker, R. C., Hirsch, V. M., & Strebel, K. (2010) · Journal of Virology · doi:10.1128/jvi.01249-10 · Cited by 50
Moderate Influence of Human APOBEC3F on HIV-1 Replication in Primary Lymphocytes
Mulder, L. C. F., Ooms, M., Majdak, S., Smedresman, J., Linscheid, C., Harari, A., Kunz, A., & Simon, V. R. (2010) · Journal of Virology · doi:10.1128/jvi.02630-09 · Cited by 47
Green, L. A., Liu, Y., & He, J. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806631200 · Cited by 23
Cited by
Mutational Processes Molding the Genomes of 21 Breast Cancers
Nik-Zainal, S., Alexandrov, L. B., Wedge, D. C., Van Loo, P., Greenman, C. D., Raine, K., Jones, D., Hinton, J., Marshall, J., Stebbings, L. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.024 · Cited by 1,909
Tzelepis, K., Koike-Yusa, H., De Braekeleer, E., Li, Y., Metzakopian, E., Dovey, O. M., Mupo, A., Grinkevich, V., Li, M., Mazan, M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.079 · Cited by 761
“We consistently observed the presence of Cas9-inactive cells in every cancer cell line tested thus far and found that these cells harbored mutations in the proviral Cas9 coding sequence with an APOBEC3 mutational signature (Hultquist et al., 2011) (Figure S2C).”
BackgroundEvidence for APOBEC3B mutagenesis in multiple human cancers
Burns, M. B., Temiz, N. A., & Harris, R. S. (2013) · Nature Genetics · doi:10.1038/ng.2701 · Cited by 755
Self-citationHarris, R. S., & Dudley, J. P. (2015) · Virology · doi:10.1016/j.virol.2015.03.012 · Cited by 551
Self-citationThe APOBEC Protein Family: United by Structure, Divergent in Function
Salter, J. D., Bennett, R. P., & Smith, H. C. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.05.001 · Cited by 408
Metadata
- Authors
- Hultquist, J. F., Lengyel, J. A., Refsland, E. W., LaRue, R. S., Lackey, L., Brown, W. L., & Harris, R. S.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2011-11
- Volume
- 85
- Issue
- 21
- Pages
- 11220-11234
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2056834613
- Cited by
- 338
- References
- 56
- FWCI
- 11.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.